DeepMed Research

BIOSENSE WEBSTER, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1970-01-01

Employees: 1K

Market Cap: -

Website: http://www.biosensewebster.com

Clinical Trials

Atrial Fibrillation Progression Trial

Phase 4

Terminated

Conditions: Atrial Fibrillation

Interventions: Device: Catheter Ablation
Drug: Drug Treatment

First Posted Date: 2012-04-04

Last Posted Date: 2025-02-04

Lead Sponsor: Biosense Webster, Inc.

Target Recruit Count: 255

Registration Number: NCT01570361

Locations: 🇩🇪
Vivantes Klinikum am Urban, Berlin, Germany
🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of
🇩🇪
University Heart Center Hamburg-Eppendorf, Hamburg, Germany

and more 33 locations

Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators

Phase 4

Terminated

Conditions: Ventricular Tachycardia
Ischemic

Interventions: Device: Catheter Ablation
Drug: Drug Treatment

First Posted Date: 2012-03-20

Last Posted Date: 2017-06-08

Lead Sponsor: Biosense Webster, Inc.

Target Recruit Count: 15

Registration Number: NCT01557842

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Cleveland Clinic Foundation, Cleveland, Ohio, United States
🇺🇸
Ohio State University, Columbus, Ohio, United States

and more 20 locations

THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation

Phase 3

Completed

Conditions: Atrial Fibrillation
Heart Diseases
Arrhythmia

Interventions: Device: THERMOCOOL® SMARTTOUCH™ Catheter

First Posted Date: 2011-06-30

Last Posted Date: 2025-02-04

Lead Sponsor: Biosense Webster, Inc.

Target Recruit Count: 172

Registration Number: NCT01385202

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
🇺🇸
Stanford University School of Medicine, Stanford, California, United States
🇺🇸
University of Kansas Hospitals, Kansas City, Kansas, United States

and more 20 locations

REVOLUTION (WFCC-133) - Treatment of Paroxysmal Atrial Fibrillation

Phase 2

Completed

Conditions: Paroxysmal Atrial Fibrillation

Interventions: Device: nMARQ™ System

First Posted Date: 2011-05-13

Last Posted Date: 2017-06-06

Lead Sponsor: Biosense Webster, Inc.

Target Recruit Count: 186

Registration Number: NCT01353586

Locations: 🇧🇪
AZ St Jan, Cardiologie, Brugge, Belgium
🇩🇪
HLG Herzzentrum Leipzig GmbH, Leipzig, Germany
🇮🇹
OFM Ospedale Generale Regionale, Acquaviva delle Fonti, Italy

and more 5 locations

Efficacy, Safety and Efficiency Study of CARTO® 3 System Guided THERMOCOOL® Catheter Ablation Versus Fluoroscopy Guided Ablation With the Pulmonary Vein Ablation Catheter® (PVAC®)

Phase 4

Terminated

Conditions: Atrial Fibrillation

Interventions: Device: Radiofrequency Ablation procedure

First Posted Date: 2010-05-05

Last Posted Date: 2025-02-03

Lead Sponsor: Biosense Webster, Inc.

Target Recruit Count: 79

Registration Number: NCT01116557

Locations: 🇳🇱
Catharina Ziekenhuis, Eindhoven, Netherlands
🇨🇦
Southlake Regional Health Centre, Ontario, Canada
🇩🇪
Krankenhaus Porz Cologne, Köln, Germany

and more 5 locations

Guided Radiofrequency Ablation Using the CARTO® 3 and NavX™ Systems for the Treatment of Paroxysmal Atrial Fibrillation

Terminated

Conditions: Paroxysmal Atrial Fibrillation

Interventions: Device: Cardiac Mapping

First Posted Date: 2009-12-21

Last Posted Date: 2017-09-27

Lead Sponsor: Biosense Webster, Inc.

Target Recruit Count: 107

Registration Number: NCT01036724

Locations: 🇨🇦
Vancouver Island Health Authority - Royal Jubilee Hospital, Victoria, British Columbia, Canada
🇨🇦
London Health Sciences, London, Ontario, Canada
🇨🇦
Southlake Regional Healthcare Centre, Newmarket, Ontario, Canada

and more 3 locations

Study of a New Catheter Using Force Sensing Capabilities for the Treatment of Atrial Fibrillation and Ventricular Tachycardia

Phase 1

Completed

Conditions: Atrial Fibrillation
Ischemic Ventricular Tachycardia

Interventions: Device: Radiofrequency Catheter Ablation

First Posted Date: 2009-12-15

Last Posted Date: 2014-12-04

Lead Sponsor: Biosense Webster, Inc.

Target Recruit Count: 22

Registration Number: NCT01032317

Locations: 🇨🇿
IKEM, Prague, Czech Republic

NAVISTAR® THERMOCOOL® Catheter Post Approval Registry

Phase 4

Completed

Conditions: Paroxysmal Atrial Fibrillation

Interventions: Procedure: Atrial fibrillation ablation

First Posted Date: 2009-08-24

Last Posted Date: 2025-02-04

Lead Sponsor: Biosense Webster, Inc.

Target Recruit Count: 437

Registration Number: NCT00964392

Locations: 🇺🇸
Ohio State University, Columbus, Ohio, United States
🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Inova Fairfax Hospital, Fairfax, Virginia, United States

and more 20 locations

Selective Complex Fractionated Atrial Electrograms (CFAE) Targeting for Atrial Fibrillation

Phase 4

Completed

Conditions: Atrial Fibrillation

Interventions: Procedure: CFAE ablation

First Posted Date: 2009-06-24

Last Posted Date: 2014-06-10

Lead Sponsor: Biosense Webster, Inc.

Target Recruit Count: 86

Registration Number: NCT00926783

Locations: 🇨🇦
Southlake Regional Health Center, Newmarket, Ontario, Canada
🇨🇦
Hamilton Health Sciences Centre, Hamilton, Ontario, Canada
🇨🇦
Hopital Laval - Institut universitaire de cardiologie et de pneumonologie, Quebec City, Quebec, Canada

and more 4 locations

CARTO 3 Human Patch Study

Withdrawn

Conditions: Healthy

Interventions: Device: ACL Patch

First Posted Date: 2008-10-07

Last Posted Date: 2015-10-14

Lead Sponsor: Biosense Webster, Inc.

Registration Number: NCT00767390

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy